Last reviewed · How we verify

NCT06379711

Cardiopulmonary Changes Following Spinal Cord Stimulation in Individuals With Spinal Cord Injury

Not yet recruiting NA Last updated 23 April 2024
What this trial tests

NA trial testing Transcutaneous Spinal Cord Stimulation (tSCS) in Spinal Cord Injuries in 22 participants. Not yet recruiting.

Timeline
1 August 2024
Primary endpoint
1 August 2028
1 August 2028

Quick facts

Lead sponsorUniversity of British Columbia
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment22
Start date1 August 2024
Primary completion1 August 2028
Estimated completion1 August 2028
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of British Columbia

Who can join

Adults 19 to 65, any sex, with Spinal Cord Injuries or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to examine the mechanisms of transcutaneous spinal cord stimulation (tSCS) for improving cardiovascular and pulmonary function in individuals with chronic motor-complete spinal cord injury (SCI) by measuring vascular related endothelial biomarkers, plasma catecholamines, and respiratory parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other University of British Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06379711.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing